Director, Cell Therapy Field Reimbursement Lead jobs in United States
cer-icon
Apply on Employer Site
company-logo

Kite Pharma · 20 hours ago

Director, Cell Therapy Field Reimbursement Lead

Kite Pharma is dedicated to curing cancer through innovative therapies, particularly CAR T-cell therapies. They are seeking a Director, Cell Therapy Field Reimbursement Lead to ensure patient access to therapy by guiding a team of Field Reimbursement Managers and overseeing reimbursement processes.

BiotechnologyHealth CareMedicalOncologyTherapeutics
check
Comp. & Benefits
check
H1B Sponsor Likelynote

Responsibilities

Design and implement SOPs, workflows, and policies for the Field Reimbursement team
Develop scalable training programs and onboarding materials for new FRMs
Establish documentation standards and operational playbooks to ensure consistency across regions
Create performance metrics and reporting tools to monitor team effectiveness and impact
Recruit, train, and manage a high-performing team of FRMs
Provide ongoing coaching, performance feedback, and career development support
Foster a culture of accountability, collaboration, and continuous improvement
Align team activities with broader Market Access and Patient Services strategies
Monitor regional performance metrics and ensure consistent execution of access initiatives
Identify trends and proactively address systemic reimbursement barriers
Ensure FRMs deliver expert guidance on benefit verification, prior authorization, site-of-care authorization (SCA), claims submission, and appeals
Oversee escalation pathways for payer delays and denials, ensuring timely resolution through internal and HUB channels
Partner with Case Management, HUB Services, Payer National Account Directors, Sales and Market Access to ensure coordinated support for ATCs
Serve as a key conduit for field insights, informing policy, strategy, and payer engagement efforts
Ensure all team activities are conducted in a compliant, non-promotional manner
Lead training initiatives to enhance FRM knowledge of billing, coding, payer policy, and institutional reimbursement models

Qualification

Reimbursement expertiseLeadership skillsCross-functional collaborationOncology experiencePayer policy navigationTraining program developmentProblem-solving skillsInterpersonal skillsPresentation skills

Required

Advanced scientific degree (i.e., MD, PharmD, PhD) and 8+ years of relevant experience OR
Master's Degree and 10+ years of relevant experience OR
Bachelor's Degree and 12+ years of relevant experience

Preferred

7+ years of experience in reimbursement, patient access, or provider support, ideally in oncology, rare disease, or cell/gene therapy
Deep expertise in buy-and-bill, institutional billing, and payer coverage policy
Proven ability to address and escalate complex payer issues including prior auth delays and denials
Prior support of autologous or CAR-T therapies
Familiarity with workflows from leukapheresis to infusion
Experience supporting academic or hospital-based treatment centers
Experience navigating and educating providers on HUB services
Strong interpersonal, presentation, and problem-solving skills

Benefits

Discretionary annual bonus
Discretionary stock-based long-term incentives (eligibility may vary based on role)
Paid time off
Company-sponsored medical, dental, vision, and life insurance plans

Company

Kite Pharma

company-logo
Kite Pharma is a biotechnology company that designs and develops immune-based therapies to treat cancer indications.

H1B Sponsorship

Kite Pharma has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (54)
2024 (47)
2023 (54)
2022 (59)
2021 (53)
2020 (38)

Funding

Current Stage
Public Company
Total Funding
$335.38M
Key Investors
Alta Partners
2017-08-28Acquired
2015-12-10Post Ipo Equity· $250.12M
2014-06-20IPO

Leadership Team

leader-logo
Craig Vermeyen
Director, Packaging and Labeling
linkedin
leader-logo
Mark Jurgens
Executive Director, Head of External Scientific Collaboration
linkedin
Company data provided by crunchbase